Drugs / Orafti®Synergy1
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04769687 | Nov 2020 → May 2023 | chronic renal failure syndrome, diabetes mellitus, noninsulin-dependent, 2 | Centre Hospitalier Universitaire de Besancon | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OraftiSynergy1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04769687 ↗ |
| Route | Oral | “can be administered orally” NCT04769687 ↗ |